Levofolinate, the biologically active enantiomer of folinic acid, is a reduced folate derivative extensively utilized in oncology as a chemoprotective agent during methotrexate therapy and as an enhancer… Read more










Levofolinate, the biologically active enantiomer of folinic acid, is a reduced folate derivative extensively utilized in oncology as a chemoprotective agent during methotrexate therapy and as an enhancer of fluoropyrimidine efficacy. The comprehensive collection of Levofolinate reference standards, which includes pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope-labelled compounds, is essential for rigorous quality control throughout the pharmaceutical lifecycle. Analytical laboratories rely on these materials for impurity profiling, allowing for the precise detection and quantification of synthesis-related byproducts and degradation species that may arise from hydrolysis, oxidation, or photolysis. These standards are critical for validating analytical methods, ensuring compliance with strict regulatory requirements such as those set by the European Pharmacopoeia, and conducting long-term stability studies to guarantee the safety and efficacy of the active pharmaceutical ingredient.